PrimeRFP SCOUT · Federal Contract Recompete Brief

CELL-BASED IMMUNOTHERAPY PRODUCTS

Contract75N91018F00077

CELL-BASED IMMUNOTHERAPY PRODUCTS is a federal award for Department of Health and Human Services (HHS) held by LEIDOS BIOMEDICAL RESEARCH, INC.. Estimated value $33M ($20M obligated). Current period of performance ends Aug 29, 2029. Place of performance: FREDERICK MD. Related solicitation N01CO5240180.

$33M
Estimated Value
$20M
Obligated
Aug 29, 2029
PoP End / Expires
More in SCOUT — score this to your firm →See related expiring contracts →
AnalysisPublic

LEIDOS BIOMEDICAL RESEARCH, INC. holds $2.3B across 187 federal awards, concentrated at Department of Health and Human Services (HHS). Recompete timing centers on the Aug 29, 2029 PoP end — agencies typically plan 12–18 months ahead.

Contract factsFederal
Contract number75N91018F00077
AgencyDepartment of Health and Human Services (HHS)
IncumbentLEIDOS BIOMEDICAL RESEARCH, INC.
CAGE3LYK6
UEIHV8BH9BPG8Y9
NAICS561210
PSCM1HA
Parent IDIQ / IDVHHSN261201500003I
Place of performanceFREDERICK MD
Pricing typeCost Plus Incentive
Extent competedNot Competed
Related solicitationN01CO5240180
PoP startSep 24, 2018
PoP end (current)Aug 29, 2029
Obligated$20M
Current value$54M
Potential value$33M
Recompete timingPublic
Expiring in 1129 days

Current PoP ends Aug 29, 2029 (1129 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Feb 29, 2028.

Track recompete timing in SCOUT →
Incumbent footprintPublic record

LEIDOS BIOMEDICAL RESEARCH, INC.$2.3B obligated across 187 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Score this to your firm →

Live Demand-Fit + Displacement scoring, alerts on verdict flips, and watchlists. Free — no card required.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open LEIDOS BIOMEDICAL RESEARCH, INC.’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Register free to start exploring SCOUT →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/HHSN261201500003I-75N91018F00077